Opthea Limited (NASDAQ:OPT), a biopharmaceutical company with a market capitalization of $894.5 million specializing in the development of novel therapies to treat eye diseases, has shared new data ...
Adverum Biotechnologies Inc (NASDAQ: ADVM) announced new data from the OPTIC study of ADVM-022 for wet age-related macular degeneration (wet AMD) during the American Society of Retina Specialists 2022 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results